The ESMO Tumour Portals allow you to find the key educational resources in your field of interest
17 Oct 2014
Dacomitinib does not show improved survival outcomes for advanced NSCLC patients when compared with placebo or erlotinib
16 Oct 2014
Lobectomy offers the highest overall survival and disease-specific survival for elderly patients with node-negative NSCLC
15 Oct 2014
Carfilzomib dose for multiple myeloma patients may be increased by extending infusion time
14 Oct 2014
L. Crino discusses current treatments available for stage IV squamous cell carcinoma of the lung and elaborates topline results from the REVEL study...
L. Crino discusses current treatments available for stage IV Squamous cell carcinoma of the lung and elaborates topline results from the REVEL study with docetaxel/ramucirumab in 2nd-line treatment for tumours of non-squamous and squamous histology, as well as the results from phase III study of gemcitabine/ cisplatin plus necitumumab in the 1st-line treatment of squamous cell carcinoma.